Skip to main content

Diagnosis and Management of Vulvar Cancer

Handbook of Gynecology
  • 182 Accesses

Abstract

Vulvar cancer is rare, comprising only 5 % of all gynecologic malignancies. However, the incidence of invasive vulvar carcinoma has been increasing moderately over the past two decades, and the incidence of in situ vulvar carcinoma has increased more than fourfold in the same period. Vulvar squamous cell carcinoma, the most common form of this cancer, is commonly divided into two basic types: HPV-associated and HPV-independent. To improve vulvar cancer survival, early detection by careful screening is important. FIGO surgical staging system for vulvar cancer was updated in 2009, incorporating prognostic factors such as inguinal lymph node metastasis. The number and morphology including the size, extracapsular spread of the involved nodes have been taken into account. The presence of fixed or ulcerated inguino-femoral nodes is also included to a staging system. The standard treatment for vulvar cancer has been primarily surgery; however, to decrease morbidity and improve survival outcome, more conservative and individualized treatment practices have recently been explored. The benefit of postoperative adjuvant therapy has been shown in the past decades; although an indication for adjuvant therapy needs further discussion. In advanced vulvar cancer, multimodality therapy including neoadjuvant chemoradiotherapy followed by surgical resection and definitive chemoradiotherapy has been investigated to avoid exenterative surgery or stoma formation. For patients with clinical positive inguino-femoral lymph nodes, node dissection or neoadjuvant chemoradiation therapy are now recommended.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Institutional subscriptions

References

  • Andrews SJ, Williams BT, DePriest PD, Gallion HH, Hunter JE, Buckley SL, et al. Therapeutic implications of lymph nodal spread in lateral T1 and T2 squamous cell carcinoma of the vulva. Gynecol Oncol. 1994;55(1):41–6.

    Article  CAS  PubMed  Google Scholar 

  • Ansink A, van der Velden J. Surgical interventions for early squamous cell carcinoma of the vulva. Cochrane Database Syst Rev. 2000;(2):CD002036.

    Google Scholar 

  • Aragona AM, Cuneo N, Soderini AH, Alcoba E, Greco A, Reyes C, et al. Tailoring the treatment of locally advanced squamous cell carcinoma of the vulva: neoadjuvant chemotherapy followed by radical surgery: results from a multicenter study. Int J Gynecol Cancer. 2012;22(7):1258–63.

    Article  PubMed  Google Scholar 

  • Bellati F, Angioli R, Manci N, Angelo Zullo M, Muzii L, Plotti F, et al. Single agent cisplatin chemotherapy in surgically resected vulvar cancer patients with multiple inguinal lymph node metastases. Gynecol Oncol. 2005;96(1):227–31.

    Article  CAS  PubMed  Google Scholar 

  • Beller U, Quinn MA, Benedet JL, Creasman WT, Ngan HYS, Maisonneuve P, et al. Carcinoma of the vulva. FIGO 26th Annual Report on the results of treatment in gynecological cancer. Int J Gynaecol Obstet. 2006;95 Suppl 1:S7–27.

    Article  PubMed  Google Scholar 

  • Beriwal S, Shukla G, Shinde A, Heron DE, Kelley JL, Edwards RP, et al. Preoperative intensity modulated radiation therapy and chemotherapy for locally advanced vulvar carcinoma: analysis of pattern of relapse. Int J Radiat Oncol Biol Phys. 2013;85(5):1269–74.

    Article  PubMed  Google Scholar 

  • Burke TW, Levenback C, Coleman RL, Morris M, Silva EG, Gershenson DM. Surgical therapy of T1 and T2 vulvar carcinoma: further experience with radical wide excision and selective inguinal lymphadenectomy. Gynecol Oncol. 1995;57(2):215–20.

    Article  CAS  PubMed  Google Scholar 

  • Cohn DE, Dehdashti F, Gibb RK, Mutch DG, Rader JS, Siegel BA, et al. Prospective evaluation of positron emission tomography for the detection of groin node metastases from vulvar cancer. Gynecol Oncol. 2002;85(1):179–84.

    Article  PubMed  Google Scholar 

  • Cunningham MJ, Goyer RP, Gibbons SK, Kredentser DC, Malfetano JH, Keys H. Primary radiation, cisplatin, and 5-fluorouracil for advanced squamous carcinoma of the vulva. Gynecol Oncol. 1997;66(2):258–61.

    Article  CAS  PubMed  Google Scholar 

  • Deppe G, Cohen CJ, Bruckner HW. Chemotherapy of squamous cell carcinoma of the vulva: a review. Gynecol Oncol. 1979;7(3):345–8.

    Article  CAS  PubMed  Google Scholar 

  • Domingues AP, Mota F, Durão M, Frutuoso C, Amaral N, de Oliveira CF. Neoadjuvant chemotherapy in advanced vulvar cancer. Int J Gynecol Cancer. 2010;20(2):294–8.

    Article  PubMed  Google Scholar 

  • Durrant KR, Mangioni C, Lacave AJ, George M, van der Burg ME, Guthrie D, et al. Bleomycin, methotrexate, and CCNU in advanced inoperable squamous cell carcinoma of the vulva: a phase II study of the EORTC Gynaecological Cancer Cooperative Group (GCCG). Gynecol Oncol. 1990;37(3):359–62.

    Article  CAS  PubMed  Google Scholar 

  • Dursenbey KE, Carlson JW, LaPorte RM, Unger JA, Goswitz JJ, Roback DM, et al. Radical vulvectomy with postoperative irradiation for vulvar cancer: therapeutic implications of a central block. Int J Radiat Oncol Biol Phys. 1994;29(5):989–98.

    Article  Google Scholar 

  • Garbe C, Peris K, Hauschild A, Saiag P, Middleton M, Spatz A, et al. Diagnosis and treatment of melanoma: European consensus-based interdisciplinary guideline. Eur J Cancer. 2010;46(2):270–83.

    Article  PubMed  Google Scholar 

  • Geisler JP, Manahan KJ, Buller RE. Neoadjuvant chemotherapy in vulvar cancer: avoiding primary exenteration. Gynecol Oncol. 2006;100(1):53–7.

    Article  CAS  PubMed  Google Scholar 

  • Gordinier ME, Malpica A, Burke TW, Bodurka DC, Wolf JK, Jhingran A, et al. Groin recurrence in patients with vulvar cancer with negative nodes on superficial inguinal lymphadenectomy. Gynecol Oncol. 2003;90(3):625–8.

    Article  PubMed  Google Scholar 

  • Gunturi A, McDermott DF. Nivolumab for the treatment of cancer. Expert Opin Investig Drugs. 2015;24(2):253–60.

    Article  CAS  PubMed  Google Scholar 

  • Hacker NF, Van der Velden J. Conservative management of early vulvar cancer. Cancer. 1993;71(4 Suppl):1673–7.

    Article  CAS  PubMed  Google Scholar 

  • Hacker NF, Leuchter RS, Berek JS, Castaldo TW, Lagasse LD. Radical vulvectomy and bilateral inguinal lymphadenectomy through separate groin incisions. Obstet Gynecol. 1981;58(5):574–9.

    CAS  PubMed  Google Scholar 

  • Hacker NF, Berek JS, Juillard GJ, Lagasse LD. Preoperative radiation therapy for locally advanced vulvar cancer. Cancer. 1984a;54(10):2056–61.

    Article  CAS  PubMed  Google Scholar 

  • Hacker NF, Berek JS, Lagasse LD, Nieberg RK, Leuchter RS. Individualization of treatment for stage I squamous cell vulvar carcinoma. Obstet Gynecol. 1984b;63(2):155–62.

    CAS  PubMed  Google Scholar 

  • Hacker NF, Eifel PJ, van der Velden J. Cancer of the vulva. Int J Gynecol Obstet. 2012;119:S90–6.

    Article  Google Scholar 

  • Halperin EC, Brady LW, Perez CA, Wazer DE. Perez & Brady’s principles and practice of radiation oncology. 6th ed. Philadelphia. Lippincott Williams & Wilkins; 2013.

    Google Scholar 

  • Heaps JM, Fu YS, Montz FJ, Hacker NF, Berek JS. Surgical-pathologic variables predictive of local recurrence in squamous cell carcinoma of the vulva. Gynecol Oncol. 1990;38(3):309–14.

    Article  CAS  PubMed  Google Scholar 

  • Hoffman JS, Kumar NB, Morley GW. Prognostic significance of groin lymph node metastases in squamous carcinoma of the vulva. Obstet Gynecol. 1985;66(3):402–5.

    CAS  PubMed  Google Scholar 

  • Homesley HD, Bundy BN, Sedlis A, Yordan E, Berek JS, Jahshan A, et al. Assessment of current International Federation of Gynecology and Obstetrics staging of vulvar carcinoma relative to prognostic factors for survival (a Gynecologic Oncology Group study). Am J Obstet Gynecol. 1991;164(4):997–1003.

    Article  CAS  PubMed  Google Scholar 

  • Homesley HD, Bundy BN, Sedlis A, Yordan E, Berek JS, Jahshan A, et al. Prognostic factors for groin node metastasis in squamous cell carcinoma of the vulva (a Gynecologic Oncology Group study). Gynecol Oncol. 1993;49(3):279–83.

    Article  CAS  PubMed  Google Scholar 

  • Horowitz NS, Olawaiye AB, Borger DR, Growdon WB, Krasner CN, Matulonis UA, et al. Phase II trial of erlotinib in women with squamous cell carcinoma of the vulva. Gynecol Oncol. 2012;127(1):141–6.

    Article  CAS  PubMed  Google Scholar 

  • De Hullu JA, Hollema H, Lolkema S, Boezen M, Boonstra H, Burger MPM, et al. Vulvar carcinoma: the price of less radical surgery. Cancer. 2002;95(11):2331–8.

    Article  PubMed  Google Scholar 

  • Judson PL, Habermann EB, Baxter NN, Durham SB, Virnig BA. Trends in the incidence of invasive and in situ vulvar carcinoma. Obstet Gynecol. 2006;107(5):1018–22.

    Article  PubMed  Google Scholar 

  • Kim KW, Shinagare AB, Krajewski KM, Howard SA, Jagannathan JP, Zukotynski K, et al. Update on imaging of vulvar squamous cell carcinoma. Am J Roentgenol. 2013;201(1):147–57.

    Article  Google Scholar 

  • Kunos C, Simpkins F, Gibbons H, Tian C, Homesley H. Radiation therapy compared with pelvic node resection for node-positive vulvar cancer: a randomized controlled trial. Obstet Gynecol. 2009;114(3):537–46.

    Article  PubMed  Google Scholar 

  • Landoni F, Maneo A, Zanetta G, Colombo A, Nava S, Placa F, et al. Concurrent preoperative chemotherapy with 5-fluorouracil and mitomycin C and radiotherapy (FUMIR) followed by limited surgery in locally advanced and recurrent vulvar carcinoma. Gynecol Oncol. 1996;61(3):321–7.

    Article  CAS  PubMed  Google Scholar 

  • Leitao MM, Cheng X, Hamilton AL, Siddiqui NA, Jurgenliemk-Schulz I, Mahner S, et al. Gynecologic Cancer InterGroup (GCIG) consensus review for vulvovaginal melanomas. Int J Gynecol Cancer. 2014;24(9 Suppl 3):S117–22.

    Article  PubMed  Google Scholar 

  • Maggino T, Landoni F, Sartori E, Zola P, Gadducci A, Alessi C, et al. Patterns of recurrence in patients with squamous cell carcinoma of the vulva. A multicenter CTF Study. Cancer. 2000;89(1):116–22.

    Article  CAS  PubMed  Google Scholar 

  • Mahner S, Jueckstock J, Hilpert F, Neuser P, Harter P, de Gregorio N, et al. Adjuvant therapy in lymph node-positive vulvar cancer: the AGO-CaRE-1 study. J Natl Cancer Inst. 2015;107(3):dju426.

    Google Scholar 

  • Matsuo K, Whitman SA, Blake EA, Conturie CL, Ciccone MA, Jung CE, et al. Feto-maternal outcome of pregnancy complicated by vulvar cancer: a systematic review of literature. Eur J Obstet Gynecol Reprod Biol. 2014;179:216–23.

    Article  PubMed  Google Scholar 

  • Montana GS, Thomas GM, Moore DH, Saxer A, Mangan CE, Lentz SS, et al. Preoperative chemo-radiation for carcinoma of the vulva with N2/N3 nodes: a Gynecologic Oncology Group study. Int J Radiat Oncol Biol Phys. 2000;48(4):1007–13.

    Article  CAS  PubMed  Google Scholar 

  • Moore DH, Thomas GM, Montana GS, Saxer A, Gallup DG, Olt G. Preoperative chemoradiation for advanced vulvar cancer: a phase II study of the Gynecologic Oncology Group. Int J Radiat Oncol Biol Phys. 1998;42(1):79–85.

    Article  CAS  PubMed  Google Scholar 

  • Moore DH, Ali S, Koh W-J, Michael H, Barnes MN, McCourt CK, et al. A phase II trial of radiation therapy and weekly cisplatin chemotherapy for the treatment of locally-advanced squamous cell carcinoma of the vulva: a Gynecologic Oncology Group study. Gynecol Oncol. 2012;124(3):529–33.

    Article  CAS  PubMed  Google Scholar 

  • Morrow CP, Curtin JP. Tumors of the vulva. In: Synopsis of gynecologic oncology. 5th ed. New York: Churchill Livingstone; 1998. p. 61–87.

    Google Scholar 

  • Pecorelli S, Zigliani L, Odicino F. Revised FIGO staging for carcinoma of the vulva, cervix, and endometrium. Int J Gynecol Obstet. 2009;105(2):107–8. Elsevier B.V.

    Article  Google Scholar 

  • de Sanjosé S, Alemany L, Ordi J, Tous S, Alejo M, Bigby SM, et al. Worldwide human papillomavirus genotype attribution in over 2000 cases of intraepithelial and invasive lesions of the vulva. Eur J Cancer. 2013;49(16):3450–61.

    Article  PubMed  Google Scholar 

  • Siegel RL, Miller KD, Jemal A. Cancer statistics. CA Cancer J Clin. 2015;65(1):5–29.

    Article  PubMed  Google Scholar 

  • Stehman FB, Bundy BN, Dvoretsky PM, Creasman WT. Early stage I carcinoma of the vulva treated with ipsilateral superficial inguinal lymphadenectomy and modified radical hemivulvectomy: a prospective study of the Gynecologic Oncology Group. Obstet Gynecol. 1992;79(4):490–7.

    CAS  PubMed  Google Scholar 

  • Stehman FB, Bundy BN, Ball H, Clarke-Pearson DL. Sites of failure and times to failure in carcinoma of the vulva treated conservatively: a Gynecologic Oncology Group study. Am J Obstet Gynecol. 1996;174(4):1128–32.

    Article  CAS  PubMed  Google Scholar 

  • Tans L, Ansink AC, van Rooij PH, Kleijnen C, Mens JW. The role of chemo-radiotherapy in the management of locally advanced carcinoma of the vulva: single institutional experience and review of literature. Am J Clin Oncol. 2011;34(1):22–6.

    Article  PubMed  Google Scholar 

  • Tantipalakorn C, Robertson G, Marsden DE, Gebski V, Hacker NF. Outcome and patterns of recurrence for International Federation of Gynecology and Obstetrics (FIGO) stages I and II squamous cell vulvar cancer. Obstet Gynecol. 2009;113(4):895–901.

    Article  PubMed  Google Scholar 

  • Tropé C, Johnsson JE, Larsson G, Simonsen E. Bleomycin alone or combined with mitomycin C in treatment of advanced or recurrent squamous cell carcinoma of the vulva. Cancer Treat Rep. 1980;64(4–5):639–42.

    PubMed  Google Scholar 

  • Wagenaar HC, Colombo N, Vergote I, Hoctin-Boes G, Zanetta G, Pecorelli S, et al. Bleomycin, methotrexate, and CCNU in locally advanced or recurrent, inoperable, squamous-cell carcinoma of the vulva: an EORTC Gynaecological Cancer Cooperative Group Study. European Organization for Research and Treatment of Cancer. Gynecol Oncol. 2001;81(3):348–54.

    Article  CAS  PubMed  Google Scholar 

Download references

Disclosure

The authors have declared that no conflicts of interest exist.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Mariko Shindo .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2016 Springer International Publishing Switzerland

About this entry

Cite this entry

Shindo, M., Ueda, Y., Kimura, T., Matsuo, K. (2016). Diagnosis and Management of Vulvar Cancer. In: Shoupe, D. (eds) Handbook of Gynecology. Springer, Cham. https://doi.org/10.1007/978-3-319-17002-2_9-1

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-17002-2_9-1

  • Received:

  • Accepted:

  • Published:

  • Publisher Name: Springer, Cham

  • Online ISBN: 978-3-319-17002-2

  • eBook Packages: Springer Reference MedicineReference Module Medicine

Publish with us

Policies and ethics

Chapter history

  1. Latest

    Diagnosis and Management of Vulvar Cancer
    Published:
    11 February 2017

    DOI: https://doi.org/10.1007/978-3-319-17002-2_9-2

  2. Original

    Diagnosis and Management of Vulvar Cancer
    Published:
    10 May 2016

    DOI: https://doi.org/10.1007/978-3-319-17002-2_9-1